Last reviewed · How we verify

NCT04364906

Comparison of the Effects of QLB 2 and QLB 3 on Post-operative Analgesia in Cesarean Section Surgery

Completed NA Last updated 19 April 2021
What this trial tests

NA trial testing Regional anesthesia in Analgesia in 80 participants. Completed in 15 September 2020.

Timeline
29 April 2020
Primary endpoint
15 September 2020
15 September 2020

Quick facts

Lead sponsorOndokuz Mayıs University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposesupportive care
Enrollment80
Start date29 April 2020
Primary completion15 September 2020
Estimated completion15 September 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ondokuz Mayıs University

Who can join

Adults 18 to 45, female only, with Analgesia or Acute Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the post-operative analgesic effects of quadratus lomborum block 2 and 3 (QLB 2, 3) in patients having cesarean section with spinal anesthesia. Spinal anesthesia will be performed to all patients for the surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Regional anesthesia

Trials testing the same drug.

Other recruiting trials for Analgesia

Currently open trials in the same condition.

Other Ondokuz Mayıs University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04364906.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing